Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 15 Show results per page	View Search Criteria \| Help With Results

Last Modified: 5/14/2007 First Published: 4/1/1998


1.		Phase III Randomized Study Comparing Granisetron versus Metoclopramide in Combination with Dexamethasone in the Prophylaxis of Chemotherapy-Induced Delayed Emesis

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				18 and over								SWS-SAKK-90/95 EU-97035, NCT00003213


2.		Phase III Adjuvant Chemotherapy with Intravesical ADR Alone and in Combination with Systemic cis-Platinum and 5-FU in Adult Patients with Superficial Bladder Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								MSUCTC-8417 NCI-V85-0102

Last Modified: 2/1/1989


3.		Phase III Trial of ICS 205-930 vs a Metoclopramide-Containing Antiemetic Cocktail for the Prevention of Cisplatin-Induced Emesis in Patients with non-Small Cell Lung Cancer or Cancer of the Head and Neck (Summary Last Modified 02/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				over 18								EORTC-08881

Last Modified: 2/1/1992


4.		Phase III, Double-Blind, Multiple Dose Study of Intranasal Metoclopramide vs Placebo in Cancer Patients Treated with Emetogenic Chemotherapy (Summary Last Modified 02/92)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				18 and over								MSKCC-91118 NCI-V91-0197


5.		Randomized Double-Blind Comparison of Metoclopramide vs Tetrahydrocannabinol to Control CACP-Induced Vomiting

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Supportive care				Closed				18 and over								MSKCC-8127


6.		Phase I/II Regional Chemotherapy with CACP/DCM for Advanced Head and Neck Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 and over				NCI				UAB-154 NCI-T83-1229D, T83-1229

Last Modified: 2/1/1991


7.		Phase I/II Study of Escalating Single Doses of Metoclopramide Given in Combination with Dexamethasone and Lorazepam for the Control of Cisplatin-Induced Nausea and Vomiting (Summary Last Modified 02/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Supportive care				Completed				30 and over								MSKCC-88074 NCI-V88-0580

Last Modified: 11/1/2001 First Published: 11/1/2001


8.		Phase II Randomized Study of High-Dose Metoclopramide for Doxorubicin and Cyclophosphamide-Induced Nausea and Vomiting in Patients With Soft Tisuue Sarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care, Treatment				Completed				18 and over				NCI				NCI-83-C-72 NCI-T83-1453


9.		Phase II Induction Chemotherapy with High-Dose CACP in Hypertonic Saline for Patients with Advanced Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified				NCI				MSKCC-8487R NCI-T84-0410D, T84-0410

Last Modified: 7/1/1990


10.		Phase II Study of Antiemesis with MDM (Midazolam/Dexamethasone/Metoclopramide) in Patients Receiving High-Dose Cisplatin (Summary Last Modified 07/90)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Completed				18 and over								MSKCC-88143 NCI-V89-0039

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute